𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): Results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials

✍ Scribed by Mark Lebwohl; Craig Leonardi; Christopher E.M. Griffiths; Jörg C. Prinz; Philippe O. Szapary; Newman Yeilding; Cynthia Guzzo; Shu Li; Ming-Chun Hsu; Bruce Strober


Book ID
116588119
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
243 KB
Volume
66
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES